Clinical Trial Update: Flu Vaccine Study in Neuromuscular Patients 2011 [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on a flu vaccine study in pediatric neuromuscular disease patients has completed, with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Muscular Dystrophy
• Duchenne Muscular Dystrophy
• Spinal Muscular Atrophy

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Duchenne Muscular Dystrophy, Spinal Muscular Atrophy | Phase 4 | Status: COMPLETED | Results posted: 2020-10-19